Cargando…

Synthesis and preliminary evaluation of octreotate conjugates of bioactive synthetic amatoxins for targeting somatostatin receptor (sstr2) expressing cells

Targeted cancer therapy represents a paradigm-shifting approach that aims to deliver a toxic payload selectively to target-expressing cells thereby sparing normal tissues the off-target effects associated with traditional chemotherapeutics. Since most targeted constructs rely on standard microtubule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pryyma, Alla, Matinkhoo, Kaveh, Bu, Yong Jia, Merkens, Helen, Zhang, Zhengxing, Bénard, Francois, Perrin, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729174/ https://www.ncbi.nlm.nih.gov/pubmed/35128410 http://dx.doi.org/10.1039/d1cb00036e

Ejemplares similares

Meeting key synthetic challenges in amanitin synthesis with a new cytotoxic analog: 5′-hydroxy-6′-deoxy-amanitin
por: Pryyma, Alla, et al.
Publicado: (2020)

mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
por: Shahbaz, Muhammad, et al.
Publicado: (2015)

Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders
por: Harda, Kristof, et al.
Publicado: (2020)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Yu, Benxia, et al.
Publicado: (2017)

Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis
por: War, Sajad A, et al.
Publicado: (2012)

Retracted: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Song, Hao, et al.
Publicado: (2018)

One-Step (18)F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging
por: Kuo, Hsiou-Ting, et al.
Publicado: (2019)

Somatostatin receptors (SSTR1-5) on inhibitory interneurons in the barrel cortex
por: Lukomska, Agnieszka, et al.
Publicado: (2019)

Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR)
por: Anzola, Luz Kelly, et al.
Publicado: (2021)

Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography
por: Dude, Iulia, et al.
Publicado: (2017)

Beta cell primary cilia mediate somatostatin responsiveness via SSTR3
por: Adamson, Samantha E., et al.
Publicado: (2023)

Ulcerating Ileocolitis in Severe Amatoxin Poisoning
por: Hilty, Matthias Peter, et al.
Publicado: (2015)

Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells
por: Modarai, Shirin R., et al.
Publicado: (2016)

Severe mushroom poisoning due to amatoxin in children
por: Uher, M, et al.
Publicado: (2000)

FRI623 Beta Cell Primary Cilia Mediate Somatostatin Responsiveness Via SSTR3
por: Elizabeth Adamson, Samantha, et al.
Publicado: (2023)

Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
por: Mizutani, Gou, et al.
Publicado: (2012)

A Rare Case of Amatoxin Poisoning in the State of Texas
por: Chen, Wei-Chung, et al.
Publicado: (2012)

Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR(2)-targeted molecular fluorescence guided surgery in meningioma
por: Dijkstra, Bianca M., et al.
Publicado: (2021)

Correction to: Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR(2)-targeted molecular fluorescence guided surgery in meningioma
por: Dijkstra, Bianca M., et al.
Publicado: (2021)

Anti-SSTR2 Antibody-drug Conjugate for Neuroendocrine Tumor Therapy
por: Si, Yingnan, et al.
Publicado: (2020)

A Cyanine‐Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation
por: Heing‐Becker, Isabelle, et al.
Publicado: (2021)

Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
por: Johnson, Felix, et al.
Publicado: (2023)

Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate
por: Ma, Michelle T., et al.
Publicado: (2015)

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: de Keizer, Bart, et al.
Publicado: (2008)

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of (177)Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
por: Shah, Rashmi G., et al.
Publicado: (2021)

Identification of Somatostatin Receptor Subtype 1 (SSTR1) Gene Polymorphism and Their Association with Growth Traits in Hulun Buir Sheep
por: Li, Xue, et al.
Publicado: (2021)

“Last supper with mushroom soup”: a case report of amatoxin poisoning
por: Das, R. N., et al.
Publicado: (2007)

Chemical modification allows phallotoxins and amatoxins to be used as tools in cell biology
por: Anderl, Jan, et al.
Publicado: (2012)

Rapid, Sensitive, and Accurate Point-of-Care Detection of Lethal Amatoxins in Urine
por: Bever, Candace S., et al.
Publicado: (2020)

Lateral flow immunoassay (LFIA) for the detection of lethal amatoxins from mushrooms
por: Bever, Candace S., et al.
Publicado: (2020)

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
por: Mehta, Shreya, et al.
Publicado: (2015)

The effect of strength and endurance training on SSTR2 and SSTR5 in patients with colorectal cancer
por: Zanjani, Farhad Safari, et al.
Publicado: (2019)

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: Kwekkeboom, D. J., et al.
Publicado: (2003)

Enhancing the anti-tumour activity of (177)Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP
por: Cullinane, Carleen, et al.
Publicado: (2020)

Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning
por: Mengs, Ulrich, et al.
Publicado: (2012)

Evaluation of Met-Val-Lys as a Renal Brush Border Enzyme-Cleavable Linker to Reduce Kidney Uptake of (68)Ga-Labeled DOTA-Conjugated Peptides and Peptidomimetics
por: Bendre, Shreya, et al.
Publicado: (2020)

Molecular-Level Understanding of the Somatostatin Receptor 1 (SSTR1)–Ligand Binding: A Structural Biology Study Based on Computational Methods
por: Nagarajan, Santhosh Kumar, et al.
Publicado: (2020)

Phylogenetic analysis of the distribution of deadly amatoxins among the little brown mushrooms of the genus Galerina
por: Landry, Brandon, et al.
Publicado: (2021)

Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model
por: Ullrich, Martin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_np1r9ej8ljrrtbi34e32v071m4